Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 50S ribosomal subunit – 23S ribosomal RNA cryptic site is a secondary binding pocket for aminoglycoside antibiotics, located within the large ribosomal subunit of bacteria (Sullivan et al., 2018). While aminoglycosides are primarily known for binding to the 16S rRNA of the 30S subunit to interfere with genetic code translation, the discovery of this cryptic site in the 23S rRNA has revealed a dual-action mechanism that contributes significantly to their bactericidal efficacy (Ying et al., 2019). Binding at this site is thought to induce severe translational errors, leading to the production of misfolded or truncated proteins. These aberrant proteins subsequently integrate into the bacterial cell membrane, causing structural damage and increasing permeability, which ultimately results in rapid cell death (Wallace et al., 1973; Borovinskaya et al., 2007). This site is of particular interest in the study of antibiotic resistance, as modifications in the 23S rRNA can influence drug susceptibility. Furthermore, the structural similarity between bacterial 23S rRNA and human mitochondrial rRNA at this site underlies some of the characteristic toxicities associated with aminoglycoside therapy, such as ototoxicity and nephrotoxicity (Waters and Tadi, 2024).
Binding to the 23S rRNA cryptic site induces translational errors and promotes the production of misfolded proteins that integrate into and destabilize the bacterial cell membrane.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 50S ribosomal subunit – 23S ribosomal RNA cryptic site (23S rRNA cryptic site).